Marketers discuss content marketing programs that helped lift brands
Vivo Agency’s Tom Dudnyk and Fingerpaint’s Anne Marie White describe which programs broke through the clutter.
-
-
Outlook 2020: Predictions and trends in healthcare for the coming year
In this first of our Outlook 2020 series, Razorfish Health president David Paragamian points to the appointment of Dr. Stephen M. Hahn as commissioner of the FDA as proof positive that we are in the era of oncology.
LATEST PARTNER CONTENT
The view from a California agency: It’s different here
The California agency hosted a half-day panel discussion about why it’s different working with a West Coast firm.
Making the shift from the patient journey to the human journey
How does the human journey in healthcare differ from the patient journey? Craig Haines, chief revenue officer of Verywell, explains the broader implications of that shift for brands and marketers.
Targeted therapies: Driving change in HCP and marketer behaviors
As targeted therapies become more prevalent, how can healthcare marketers support providers and other extenders to ensure readiness to treat and prescribe these new methods?
Marketers on point-of-care programs that drove better adherence rates
Execs from Medisafe, Phreesia and Heartbeat share examples of POC programs that drove better short- and long-term adherence rates than seen before.
Marketing science summit
At W2O’s second Marketing Science Summit, pioneers in the fields of market research, social analytics and digital marketing shared the latest trends in marketing science, with a focus on the healthcare and tech industries.
Integrating engagement and adherence solutions with affordability programs
The TrialCard acquisition of San Francisco-based Mango Health is a win-win for patients and pharma.
The value personalization brings to healthcare marketing
Miriam Paramore, president and chief strategy officer of OptimizeRx, underscores the value that personalized messaging brings to the patient and to the healthcare provider.
Specialty data aggregation: Preparing for a successful launch
Best practices manufacturers can leverage to ensure accurate and timely data is available at launch and beyond.
4 unique ways firms help clients in the rare disease space
Marketers from Dudnyk, 81qd, Guidemark Health and The Bloc share their expertise.
Science-first communications
Spectrum Science’s Jonathan Wilson, CEO, Michelle Gross, president, and Justin Rubin, chief creative officer, reflect on how the agency’s strategy-first approach is evolving, going beyond the ‘science quo” to deliver media-neutral “atomic creative” for client campaigns.
Roundtables
Speaker bureaus must change to stay relevant, experts say
To remain relevant, speakers bureaus must evolve to a strategic marketing tactic with personalized messaging to the customer.
Roundtable: Market access takes center stage
Participants in this roundtable explore how digital forms of data are poised to illuminate the reimbursement pathway, as market access gets its closeup.
Roundtable: When it comes to media, pharma compares the new with the old
In apportioning their media budgets, pharma companies continue to straddle the line between new and traditional strategies.
Roundtable: Social centricity in oncology
Industry leaders discussed why a social-centric approach is especially important in oncology, particularly as it relates to health systems, interactions with healthcare providers, and family support.
Data, Technology, and Medicine: How They Intersect
The intersection of data, technology, and medicine is rapidly changing how doctors practice, drug companies market, and patients engage with the healthcare system.
